Bio-Rad Laboratories, Inc. (NYSE:BIO.B – Get Free Report) shares gapped down prior to trading on Wednesday . The stock had previously closed at $338.55, but opened at $281.55. Bio-Rad Laboratories shares last traded at $279.91, with a volume of 400 shares traded.
Bio-Rad Laboratories Stock Performance
The company has a quick ratio of 4.34, a current ratio of 5.83 and a debt-to-equity ratio of 0.14. The stock has a fifty day moving average price of $317.98 and a two-hundred day moving average price of $314.14. The company has a market capitalization of $7.98 billion, a price-to-earnings ratio of -13.03 and a beta of 0.70.
Bio-Rad Laboratories (NYSE:BIO.B – Get Free Report) last released its earnings results on Thursday, February 15th. The company reported $3.10 EPS for the quarter. Bio-Rad Laboratories had a negative net margin of 23.86% and a positive return on equity of 3.90%. The firm had revenue of $681.18 million during the quarter.
About Bio-Rad Laboratories
Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.
Read More
- Five stocks we like better than Bio-Rad Laboratories
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
- What Is WallStreetBets and What Stocks Are They Targeting?
- Generac Powers Ahead on the Electrification Mega-Trend
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- PulteGroup Wins and Wins More on Interest Rate Cuts
Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.